Skip to main content

Table 2 Summary of published clinical trials on combinations of XYS and antidepressants in the treatment of MDD

From: Effect of Xiaoyaosan on major depressive disorder

Study ID

Sample size

Diagnostic criteria

Test design

Course (weeks)

Follow-up (months)

Major outcomes

Intervention

Control

Randomizer

Blindness

Efficacy by HAMD

Clinical efficacy

Side effects

Relapse

Onset time

Wang et al. [9]

120

CCMD-3

Xiaoyao pill and duloxetine

Duloxetine

N/A

N/A

8

N/A

↑ (CGI)

NS (TESS)

N/A

N/A

Wang et al. [10]

68

CCMD-3

Xiaoyao pill and doxepin

Fluoxetine

N/A

N/A

6

N/A

NS

NS

NS (TESS)

N/A

Nan et al. [11]

61

CCMD-2-R

Xiaoyao pill and imipramine

Imipramine

N/A

N/A

8

6

NS

↑ (cure rate)

N/A

Li et al. [12]

60

CCMD-3

Xiaoyao pill and imipramine

Imipramine

N/A

N/A

8

N/A

NS

NS

N/A

Du et al. [13]

150

CCMD-3

Xiaoyao pill and fluoxetine

Amitriptyline

N/A

N/A

6

N/A

NS

NS

↓ (TESS)

N/A

Ma [14]

30

CCMD-3

Xiaoyao pill and citalopram

Citalopram

Random number table

N/A

8

12

NS

NS

↓ (TESS)

N/A

Chen [15]

61

CCMD-2-R

Xiaoyao pill and amitriptyline

Amitriptyline

N/A

N/A

6

6

↓ (TESS)

N/A

Zhai et al. [16]

24

CCMD-2-R

Xiaoyao pill and doxepin

Doxepin

N/A

N/A

8

N/A

NS

NS

(TESS)

N/A

N/A

Zhang et al. [17]

50

CCMD-3

Xiaoyao pill and fluoxetine

Fluoxetine

N/A

N/A

6

N/A

NS

NS

↓ (TESS)

N/A

Zhang et al. [18]

50

CCMD-2-R

Xiaoyao pill and fluoxetine

fluoxetine

N/A

N/A

3

N/A

N/A

↑ (Zung value)

↓ (TESS)

N/A

N/A

Xia et al. [19]

60

CCMD-3

Xiaoyao pill and citalopram

Citalopram

N/A

N/A

8

N/A

↓ (TESS)

N/A

N/A

Xiang [20]

76

CCMD-3

Xiaoyao pill and paroxetine

Paroxetine

N/A

N/A

12

12

N/A

↑ (SDS)

N/A

N/A

  1. CCMD China classification and diagnostic criteria for mental disorder, HAMD Hamilton depression scale, TESS treatment-emergent symptom side effect, SDS self-rating depression scale, CGI clinical global impression, N/A not available, NS no significant difference between intervention and control, ↑ significant increase compared with control, ↓ significant decrease compared with control.